GMT IdS.A.Active

Research and experimental development in natural sciences and engineering

KRS: 0001174137 NIP: 8952287757 REGON: 54178072000000

Overview

Registry date
2025-05-21
Share capital
$162,074.55
Activity description

Gmt Id is the creator of a mobile platform for genetic diagnostics called Genomtec ID, designed for point-of-care testing. The company has obtained a CE-IVD Mark for its GenomtecID Respiratory Panel 5-Plex, which detects viruses and bacteria responsible for respiratory tract infections, making it the only solution of its kind in Europe. Additionally, Genomtec is preparing for technology trials in Asia as part of its ongoing M&A efforts.

Registered address
Ul. Bierutowska 57-59, 51-317 Wrocław, Poland
Website
genomtec.comWebsite active
Email
Email address current
Electronic delivery address
AE:PL-18294-60055-DGCRG-32

News

Another patent granted. Another step in building global protection of Genomtec molecular diagnostics technology

Another patent granted. Another step in building global protection of Genomtec molecular diagnostics technology

Genomtec secured PLN 11 million from share issue for finalizing global M&A strategy and commercialization of breakthrough Genomtec ID and OncoSNAAT® technologies

Genomtec secured PLN 11 million from share issue for finalizing global M&A strategy and commercialization of breakthrough Genomtec ID and OncoSNAAT® technologies

Start of Genomtec public share offering to raise funds for finalizing M&A process and commercialization of Genomtec ID and OncoSNAAT® technologies

Start of Genomtec public share offering to raise funds for finalizing M&A process and commercialization of Genomtec ID and OncoSNAAT® technologies

Genomtec plans share issue. Funds will support M&A process and project commercialization. Company signed investment agreement with key shareholder.

Genomtec plans share issue. Funds will support M&A process and project commercialization. Company signed investment agreement with key shareholder.

Genomtec prepares to test its technology with potential partners in Asia as part of M&A process

Genomtec prepares to test its technology with potential partners in Asia as part of M&A process

Genomtec Supervisory Board appointed Leroy Huntley to the Management Board

Genomtec Supervisory Board appointed Leroy Huntley to the Management Board

Industry

NameCode
Research and experimental development in natural sciences and engineering
72.10.Z
Industrial design and fashion design activities
74.11.Z
Other leasing of intellectual property and similar products, except copyrighted works
77.40.B
Educational support activities
85.69.Z
Manufacture of other chemical products n.e.c.
20.59.Z

Accounts

Registered as a VAT taxpayer on 2025-11-01.Active

Authorized Representatives

Ownership

Competitors

NameRevenueWebsite
Real ResearchS.A.$565,296.66real-research.com/
Oasis DiagnosticsS.A.$282,613.94oasis-diagnostics.com
PolbionicaS.A.$225,022.81polbionica.com/
NanosanguisS.A.$133,800.85nanosanguis.com
SatroecgS.A.$117,301.57satroecg.pl
Smart FluidS.A.$100,333.00smartfluid.pl
IncellvuS.A.$82,908.93incellvu.pl
NanovelosS.A.$22,690.62nanovelos.com
ARES Shield AiS.A.$21,335.85aresshield.ai
NanotheaS.A.$12,468.28nanothea.com

Change history

EventDetailsDate
Share capital change100000.00 PLN → 600000.00 PLN2026-05-11

FAQ

Last updated: 2026-06-24